NL-OMON34244已完成不适用
A randomised controlled trail comparing the TVT-O® with the Ajust® as primary surgical treatment of female stress urinary incontinence. - TOAST
niversitair Medisch Centrum Utrecht0 个研究点目标入组 145 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 145
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Predominant stress urinary incontinence
- •2. The stress urinary incontinence is confirmed during physical examination, stress test or urodynamic assessment.
- •3. They have completed conservative treatment for their stress urinary incontinence, pelvic floor muscle training program
排除标准
- •1. A post voiding bladder volume of more than 100 ml.
- •2. History of anti-incontinence surgery
- •3. Genital prolapse Stage 2 or more according to the POP-Q classification
- •4. Patients desire for future pregnancy and childbirth
- •5. Co-morbidity
研究者
相似试验
尚未招募
2 期
Effect Of Modified Upanaha(Herbal Powder as a warm paste applied over knee joint and temparature is maintained using modified equipment) And Classical method of upanaha(Herbal Powder as a paste applied over knee joint and covered using cotton cloth) In Janusandigatavata (Osteoarthritis of Knee).CTRI/2023/10/059163Dr. AMRUTHA CHANDRA
进行中（未招募）
不适用
A comparative study in Head and Neck cancer patients of the two methods of giving oxygen to patient during operation namely THRIVE and NODEST for maintaining the sufficient blood oxygen level during throat extermination and biopsy with microscopeCTRI/2018/02/012207Tata Memorial Hospital
尚未招募
2 期
To See The Effect Of Sarvatobhadra Varti Anjana In Prastari Arma That Is Progressive PterygiumCTRI/2024/07/071273Dr Nikhita Shivkumar Pise
尚未招募
不适用
Diclofenac Patch vs inj paracetamol Following Cesarean DeliveryCTRI/2020/11/029204Armed Forces Medical College Pune
已完成
不适用
A randomized controlled study of the efficacy of Tadalafil monotherapy versus combination of Tadalafil and mirabegron for the treatment of overactive bladder (OAB) associated with benign prostatic hyperplasia (BPH)Benign prostatic hyperplasiaJPRN-UMIN000025282Clinical Research Support Center Kyushu170